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INTRODUCTION
Human allergic asthma is characterized by chronic
inflammation of the airway. Th2-type cells are thought
to be primary initiators of this reaction by producing
Th2-type cytokines such as IL-4, IL-5 and IL-13 or
by interacting with resident cells in the airway (1, 2).
Dendritic cells (DCs) or alveolar macrophage (AM)
populations were suggested to be major effectors
for the interactionwith Th2 cells (3, 4), although other
cell types such as fibroblasts or smooth muscle cells
may have some role for the interaction with T cells
(5, 6). However, there is no sufficient consensus
whether the interaction of bronchial epithelial cells
with T cells is important for the pathogenesis of air-
way inflammatory disease. Bronchial epithelial cells
produce various inflammatory cytokines including
IL-1, GM-CSF, IL-8, RANTES, TNF-α and IL-6 (7-
9). Phenotypic examination shows that these cells
express adhesion molecules of ICAM-1, VCAM-1,
VLA-4, E-selectin (10, 11) and CD40. Furthermore,
bronchial epithelial cells exhibit or can be induced to
express MHC class II antigens (12, 13) that are es-
sential for the presentation of external antigen. There-
fore, bronchial epithelial cells have some character-
istics of antigen-presenting cell (APC) that can inter-
act with T cells and can regulate the function of T
cells.
The CD40 molecule, as well as the B7 systemwere
shown to be important as co-stimulatory molecules
for the activation of T cells (14-18). CD40, a member
of the TNF receptor family, is expressed on a variety
of cell types such as B lymphocytes, dendritic cells,
macrophages, endothelial cells and epithelial cells
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(19-23). The CD40-CD40L interaction was shown to
be important for the induction of inflammatory re-
sponse in the airway (24, 25).
In the present study, we examined whether freshly
isolated human bronchial cells (HBEC) and bron-
chial epithelial cell line (BEAS-2B) cells expressed
various surface molecules required for APC function
in response to IFN-γ and whether bronchial epithelial
cells can induce T cell activation by presenting
allogeneic antigens.
MATERIALS AND METHODS
Reagents and Cell lines
Recombinant human IFN-γ (specific activity > 1.0
×107 U/mg protein) was purchased from Nippon
Roche (Tokyo, Japan). Recombinant human GM-CSF
(specific activity, 1.7×107 U/mg protein) was pur-
chased from Genzyme (Boston, MA). Recombinant
human IL-5 was from Suntory Institute for Biomedical
Research (Osaka, Japan). Recombinant human IL-4
(specific activity 1.0×106 U/mg protein) was kindly
provided by Ono Pharmaceutical Co. (Osaka, Japan).
Anti-human CD40, anti-human ICAM-1 and anti-human
HLA-DR mAbs were purchased from Pharmingen
(San Diego, CA). FITC conjugated goat anti-mouse
IgG was purchased from Immunotech (Marseille,
France). A human bronchial epithelial cell line (BEAS-2B),
transformed with SV40 virus, was purchased from
the American Type Culture Collection (Rockville,
MD). The cells at passages 43-45 were cultured in
LHC9/RPMI 1640 medium.
Isolation of Human Bronchial Epithelial cells (HBEC)
Human bronchial epithelial cells were obtained by
brushing the bronchial mucosa under bronchoscopy.
An intramuscular injection of 0.5 mg of atropine and
25 mg of hydroxyzine was administered 30min before
the examination. Fiberoptic bronchoscopywas always
carried out by the same examiner. A fiberoptic
bronchoscope (Model 1T20 ; Olympus Optical Co.,
Tokyo, Japan) was inserted into the trachea. Local
anesthesia of the bronchial mucosa was achieved with
2% lidocaine. Brushing for collection of bronchial
epithelial cells was performed in a standard manner
before procedures such as bronchoalveolar lavage,
transbronchial lung biopsy, and bronchial biopsy for
clinical purposes. The disposable brush (Model BC-15C ;
Olympus) was introduced via the bronchoscope into
subsegmental bronchi of the left B5a segment and
rubbed against the epithelial surface by 10 gentle up-
ward and downward strokes. In cases of bronchial
carcinoma with a tumor in the left bronchus, the
right subsegmental bronchuswas brushed. The cells ob-
tained by brushingwere collected in 50ml polypropylene
tubes containing 20 ml RPMI 1640 with gentamycin
by shaking the brush in the medium. The cells were
then washed twice by centrifugation at 400×g at 4℃
for 10 min for use in subsequent experiments. All pa-
tients gave informed consent to participate in the
study.
Culture of HBEC
The rinsed pellet of HBEC obtained by brushing
was resuspended in LHC9/RPMI 1640 medium. The
cells were plated in tissue culture plates with 16-mm/
diameter wells coated with a gel of type I collagen
(Vitrogen100 ; Celtrix, Santa Clara, CA), and incubated
at 37℃, under 5% CO2 in air for 7 to 10 days. The me-
dium was changed after 24 hr and then every other
day. When the cells reached confluency, they were
passaged in 48-well tissue plates. At the same time,
they were confirmed to be entirely epithelial cells by
their positive staining by the avidin-biotin complex
method (ABC kit ; VECTOR Lab., Burlingame, CA)
with monoclonal murine anti-human cytokeratin anti-
body (MAK-6 ; Triton, Alameda, CA). No cells reacted
with monoclonal murine anti-swine vimentin antibody
(DAKO-Vimentin ; DAKO, Santa Barbara, CA), which
was demonstrated to stain fibroblast IMR-90 cells pro-
vided by Tokyo Metropolitan Institute of Gerontology
(Tokyo, Japan). At the time of semiconfluency, cells
were used in experiments.
Isolation and purification of lymphocytes and CD4 +
cells
Leukocyte concentrates from healthy donors were
separated into peripheral blood mononuclear cells
(PBMC) by density gradient centrifugation in lympho-
cyte separationmedium. Subsequently, PBMCwere sepa-
rated into lymphocytes and monocytes by counterflow
centrifugal elutriation inaBeckmanJE-5.0 rotor (Beckman
Instruments, Inc., Fullerton, CA). The lymphocyte-rich
fraction was collected at flow rate of 12 to 16 ml/min
at 2000 rpm. The purity of the lymphocyte fraction
was determined by morphologic examination and was
more than 99%. CD4+ cells were isolated from this
lymphoid fraction by incubation with CD4-specific
Dynabeads, followed by Detatchabead treatment, as
indicated by the manufacture (Dynabeads, Oslo, Nor-
way). This procedure yielded a population of > 98%
CD4+ cells, as determined by FACS analysis.
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Analysis by flow microfluorometry
HBEC or BEAS-2B cells were cultured for 3 days
in the presence or absence of IFN-γ, GM-CSF, IL-4,
IL-5 and LPS. The cells were harvested by 0.125%
tripsin containing 0.02% EDTA. The single cell sus-
pensions were incubated with mAb against CD40,
HLA-DR and ICAM-1 for 30 min at 4℃ in PBS con-
taining 1% FBS. Then, cells were washed twice with
PBS containing 1% FBS. The stained cells were mea-
sured by FACStationTM (Becton Dickinson, Mountain
View, CA) using CellQuest software.
Measurement of T cell proliferation
Purified lymphocytes or CD4+ cells (1×105/well) were
cocultured with BEAS-2B or allogeneicmononuclear cells
(MNC) for 4 days under the presence of a suboptimal
dose of Con A (5 µg/ml) at a ratio of 1 : 5 in LHC9/RPMI
1640 containing 10% FBS in a 96-well microplate at
37℃ under 5% CO2. BEAS-2B cells used for stimu-
lation were cultured with or without IFN-γ (100 U/ml)
for 3 days before the experiment. Allogeneicmononuclear
cells were prepared from blood of healthy donors
by density gradient centrifugation in lymphocyte sepa-
ration medium. Stimulator cells were pretreated with
25 µg/ml of MMC for 30 min. After 4 days of incu-
bation, 1 µCi/well of 3H-thymidine (Amersham Ar-
linton Height, IL) was added and further incubated for
20 hr. The cells were harvested on a glass filter with
a cell harvester (Labo Mash, Tokyo, Japan). The in-
corporation of 3H-thymidine was examined in a liquid
scintillation counter (LSC-3500 ; Aloka, Tokyo, Japan).
RESULTS
Expression of CD40 molecules on bronchial epi-
thelial cells and the enhancement by IFN-γ
CD40 is an important co-stimulatory molecule which
is responsible for initiation of the inflammatory reac-
tion. We then evaluated the expression of CD40 on
BEAS-2B cells and HBEC by culturing with or with-
out IFN-γ for 3 days. The expression of CD40 was
detectable, but the expression level was low in BEAS-2B
and HBEC cells (Fig. 1). Treatment with IFN-γ en-
hanced the expression of CD40 about 5-fold in mean
fluorescence intensity in these cells. This enhance-
ment was dose-dependent and the expression reached
maximum at 2 or 3 days of incubation (data not shown).
In the subsequent experiments, we used the maxi-
mum level of IFN-γ (100 U/ml).
Induction of HLA-DR expression on bronchial epi-
thelial cells by IFN-γ
Expression of class II molecules is necessary for
the presentation of external antigens. To ascertain
the ability of HBEC or BEAS-2B cells to express class
II antigen, these cells were cultured with IFN-γ for
3 days and the expression of HLA-DR was assessed.
Although HBEC and BEAS-2 B cells did not express
HLA-DR in the resting condition without IFN-γ, both
of these cells expressed significantHLA-DR after IFN-γ
treatment (Fig. 2). HLA-DR expression was induced
Fig. 1. Expression of CD40 on BEAS-2B cells and HBEC. BEAS-2B
cells and HBEC were cultured for 3 days with or without IFN-γ
(100 U/ml). These cells were stained with anti-CD40 (thin line)
or only with second antibody (broken line). The expression of
CD40 was examined by FACStationTM.
Fig. 2. Induction of HLA-DR expression on BEAS-2B cells and
HBEC by IFN-γ. BEAS-2B cells and HBEC were cultured for 3
days with or without IFN-γ (100 U/ml). These cells were stained
with anti-HLA-DR (broken line) or only with second antibody (thin
line). The expression of HLA-DR was examined by FACStationTM.
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dose-dependently and reached maximum after 3
to 4 days of incubation (data not shown).
Expression of co-stimulatory molecules other than
CD40 on bronchial epithelial cells and the regula-
tion by IFN-γ
We examined the expression of the co-stimulatory
molecules other than CD40 in HBEC and BEAS-2B
cells. ICAM-1 expression, but no expression of B 7-1
or B7-2 was detected under the resting condition
(Fig. 3). In a parallel experiment, treatment with
IFN-γ strongly enhanced the expression of ICAM-1
especially in HBEC up to 100-fold in mean fluores-
cence intensity, but no induction of B7-1 or B7-2 was
obsereved. These changes in adhesion molecule ex-
pression were similar in both of these cells.
Selective requirement of IFN-γ for the expression
of HLA-DR antigen on BEAS-2B cells
The inflammatory reaction of asthma was often seen in
Th2 cell dominant conditions (1, 2) Therefore, we exam-
ined whether Th2 cytokines or other proinflammatory
cytokine such as IL-4, IL-5 and GM-CSF could induce
the expression of HLA-DR on BEAS-2B cells. However,
all the cytokines employed in this experiment except
IFN-γ did not cause HLA-DR induction on BEAS-2B
cells (Fig. 4). Nonspecific strong stimulator LPS also
did not induce the expression of HLA-DR. Therefore,
IFN-γ appeared to be a selective inducer for HLA-DR
expression on human bronchial epithelial cells.
Allogeneic lymphocytes, but not purified CD4+ cells
proliferated in response to BEAS-2B cells stimulated
with IFN-γ
Lymphocytes (T cells and B cells) or CD4+ cells
purified from peripheral bloodMNCwere co-cultured
for 5 days with BEAS-2B cells pretreated with or
without IFN-γ or allogeneic MNC. Allogeneic lympho-
cytes strongly proliferated in response to BEAS-2B
cells treated with IFN-γ. In contrast, untreatedBEAS-2B
cells induced only minor proliferation of lymphocytes
(Fig. 5). The enhancement of T cell proliferation by
BEAS-2B cells cultured with IFN-γ was attributable
to the expression of class II antigen and the enhanced
Fig. 3. Exprssion of B7-1, B7-2 and
ICAM-1 on BEAS-2B cells and HBEC
under the presence or absence of IFN-γ.
BEAS-2B cells (A) and HBEC (B) were
cultured for 3 days with or without IFN-γ
(100 U/ml). These cells were stained
with anti-B7-1, anti-B7-2, anti-ICAM-1
(broken line) or only with second anti-
body (thin line). The expression of
HLA-DR was examined by FACStationTM.
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expression of co-stimulatory molecules such as CD40
or ICAM-1. In a parallel experiment, when purified
CD4+ cells were used as responder cells, prolifera-
tion of T cells to IFN-γ-treated BEAS-2B cells was
almost completely abolished. Thus, the co-stimulatory
signal delivered from non-CD4+ cells in the lymphoid
population is required for the induction of T cell
proliferation.
Effect of anti-CD40 mAb on the proliferation of T
cells to BEAS-2B cells
The CD40 molecule was constantly expressed on
bronchial epithelial cells. We next examined whether
blockade of the CD40-CD40L interaction by anti-CD40
mAb affected the allogeneic reaction of lymphocytes
to bronchial epithelial cells in terms of T cell acti-
vation. Although T cell proliferation to allogeneic
MNC was only partially affected by treatment with
anti-CD 40 mAb, T cell proliferation to IFN-γ-treated
BEAS-2B cells was strongly suppressed (Fig. 6). The
inhibitory effect of anti-CD40 mAb was also found in
the T cell response to non-treatedBEAS-2B cells. Thus,
the CD40 molecule appeared to be involved in the
class I response as well as class II response. The
CD40 molecule may be essential for bronchial epi-
thelial cells rather than for professional APC to inter-
act with T cells, since bronchial epithelial cells did
not express other co-stimulatory molecules of B7-1
and B7-2.
DISCUSSION
There is accumulating evidence that Th2 cells are
primary initiators of asthmatic inflammatory reac-
tions (1, 2). DCs or AMwere suggested to be themain
populations for presentation of external antigen to
T cells in the airway (3, 4). The interaction of T cells
with other resident cells such as smooth muscle cells
or fibroblast cells was also suggested to be involved
in the pathogenesis of pulmonary inflammation (5,
6). However, the importance of the interaction be-
tween bronchial epithelial cells and T cells has not
been sufficiently evaluated.
Fig. 4. No induction of HLA-DR expression
by IL-4, IL-5, GM-CSF and LPS on BEAS-2B
cells. BEAS-2B cells were cultured for 3 days
withmedium, IL-4 (100 U/ml), IL-5 (100U/ml),
GM-CSF (100 U/ml), LPS (5 µg/ml), or IFN-γ
(100U/ml). After harvesting, these cells were
stained with anti-HLA-DR (broken line) or only
with second antibody (thin line). The expres-
sion of HLA-DRwas examinedbyFACStationTM.
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Fig. 5. Proliferation response of T cells to the stimulation with
BEAS-2B cells. BESA-2B cells were precultured with or without
IFN-γ (100 U/ml) for 3 days. CD4+ cells or lymphocytes (Ly)
purified from peripheral blood were cultured with IFN-γ treated
BEAS2B, untreated BEAS-2 B or allogeneic MNC for 5 days. T
cell proliferation was quantitated by 3H-thymidine incorpora-
tion (see Materials and Methods). *, p≦0.01, compared with
untreated BEAS-2B
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In the present study, to explore the possibility of
the APC function of bronchial epithelial cells, we ex-
amined whether human bronchial epithelial cells ac-
tivate T cells by presenting allogeneic antigen. First,
the present study clearly showed that IFN-γ induced
the expression of HLA-DR and augmented the ex-
pression of ICAM-1 and CD40 on BEAS-2B and HBEC
cells. Moreover, functional analysis showed that BEAS-2B
cells stimulated the proliferation of allogeneic lympho-
cytes (mixture of T and B cells) when BEAS-2B cells
were cultured with IFN-γ. Thus, BEAS-2B cells have
the ability to induce a class II response under the
presence of IFN-γ. However, untreated BEAS-2B cells
have a minor effect on T cell proliferation probably
due to the response to class I antigen only.
When purified CD4+ T cells were used as a respond-
er, the stimulatory effect of BEAS-2B cells was almost
completely abolished compared with that of allogeneic
MNC. Here, we showed no induction of B7-1 or B7-2
expression by IFN-γ in HBEC and BEAS-2B cells.
Furthermore, in a separate experiment, we found that
these two molecules in BEAS-2B cells were also not
induced by CD40 stimulation (data not shown). Pre-
vious studies showed that resting B cells express
CD40 (19) and B7-2 but not B7-1 (26). These find-
ings raised one possibility that B cells in the lymph-
oid populations could deliver co-stimulatory signals
for activation of T cells, although there was a con-
troversial study where CD40 expressed on B cells was
rather inhibitory in the interaction of T cells and
APC (27).
Blockade of the CD40-CD40L interaction by CD40
mAb resulted in inhibition of the T cell proliferation
induced by BEAS-2B cells independent of whether
these cells were treated with IFN-γ. Taken together
with the findings using purified CD4+ T cells, signaling
from CD40 is essential for the activation of CD4+ T
cells. The CD40Lmolecule is also expressed on CD8+
T cells (28, 29) as well as on CD4+ T cells and is in-
volved in the immune response of the intestine (30).
Anti-CD40 treatment may also inhibit the response
of CD8+ T cells to untreated BEAS-2B cells.
In the mucosal area of the intestine, the immune
response is regulated through antigen presentation
by mucosal epithelial cells (31-33). The mechanism
of interaction between intestinal epithelial cells and
T cells is well documented (34, 35). When external
antigens are presented via the mucosal (oral or nasal)
route, no T cell response is induced (36 -38). Co-stimulatory
molecules such as B7 and CD40 are involved in this
regulation (39, 40). Moreover, there are studies showing
that IFN-γ is important for the induction of mucosal
tolerance (37, 41). Consistent with these previous
findings, we observed that the interaction between
bronchial epithelial cells and T cells was also CD 40
and IFN-γ dependent. This interaction may be impor-
tant for the control of the overreaction of T cells in
the airway through the mimicked mechanism of ac-
tivation induced cell death (42-44). The potentials
of APC function by bronchial epithelial cells was induced
selectively by IFN-γ, but not by Th2-type cytokines
of IL-4 and IL-5, proinflammatory cytokine of GM-CSF
and non-specific stimulator LPS. There are several
studies showing that increased production of IFN-γ
reduced the allergic condition including bronchial
asthma (45-47). It is possible that interaction between
epithelial cells and T cells is insufficient in asthmatic
patients due to the Th2 dominant conditions.
In conclusion, the present findings indicated that
bronchial epithelial cells have characteristic features
of APC in terms of phenotype and function, and that
APC function of bronchial epithelial cells could be
mediated by IFN-γ and CD40 dependent mechanism
under the presence of third party cells. Further ex-
periments are required to confirm whether naive
bronchial epithelial cells can function as APC.
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Fig. 6. Inhibition of T cell proliferation by anti-CD40 treatment.
BEAS-2B cells were precultured with or without IFN-γ (100 U/ml)
for 3 days. Lymphocytes purified from peripheral blood were
cultured with IFN-γ treated BEAS-2B, untreated BEAS-2B orMNC
for 5 days under the presence of anit-CD40 or control IgG. T cell
proliferation was quantitated by 3H-thymidine incorporation (see
Materials and Methods). *, p≦0.05, compared with the respec-
tive IgG treatments.
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